The Use and Monitoring of Antithrombotic Drug Therapy. The Need for a New Approach

• References

• 1 Alkjaersig N, Roy L, Fletcher A, Murphy E. 1973; Analysis of gel exclusion chromatographic data by chromatographic plate theory analysis: Application to plasma fibrinogen chromatography. Thrombosis Research 3: 525.
• 2 Alkjaersig N, Fletcher A, Burstein R. 1975; Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatography. American Journal of Obsterics and Gynaecology 122: 199.
• 3 Alkjaersig N, Fletcher A, Joist J, Chaplin Jr. J. 1976; a Hemostatic alterations accompanying sickle cell pain crisis. Journal of Laboratory and Clinical Medicine 88: 440.
• 4 Alkjaersig N, Fletcher A, Lewis M, Cole B, Ingelfinger J, Robson A. 1976; b Pathophysiological response of blood coagulation system in acute glomerulonephritis. Kidney International 10: 319.
• 5 Alkjaersig N, Davies A, Fletcher A. 1977; Fibrinogen and fibrinogen proteolysis products: Comparison between gel filtration and SDS polyacrylamide electrophoresis analysis. Thrombosis and Haemostasis 38: 524.
• 6 Anaya-Galindo R, Shattil S. J, Shelburne J. C, Colman R. W. 1976; Soluble fibrin complexes in coronary disease. Thrombosis Research 9: 153.
• 7 Bang N, Chang M. 1974; Soluble fibrin complexes. Seminar in Thrombosis and Haemostasis 1: 91.
• 8 Brass E. P, Forman W. B, Edwards R. V, Lindan O. 1976; Fibrin formation: The role of the fibrinogen-fibrin complex. Thrombosis and Haemostasis 36: 37.
• 9 Cash J. D, Ludlam C. 1977 Beta-thromboglobulin. A new diagnostic tool for the diagnosis of hypercoagulability. In: Serneri G. G. N, Gensini G. F, Abbate R. (eds.) First Florence Conference on Haemostasis and Thrombosis. Serono Symposia. 10–12 May 1977: 20.
• 10 Dugdale M, Masi A. 1969. Effects of the oral contraceptives on blood clotting. In: Second annual report on the oral contraceptives advisory committee on Obstetrics/Gynaecology. Federal Drug Administration, U. S. Government Printing Office; Washington, D.C.: 1969: 43.
• 11 Fletcher A. P. 1969. Thrombolytic Agents. In: Sherry S, Brinkhous K. M, Genton E, Stengle J. M. (eds.) Thrombosis. National Academy of Sciences; Washington, D. C.: 1969: 710.
• 12 Fletcher A, Alkjaersig N, O’Brien J, Tulevski V. 1970; Blood hypercoagulability and thrombosis. Transactions of the Association of American Physicians 83: 159.
• 13 Fletcher A, Alkjaersig N, Roy L, Owens O. 1973. Early detection of blood hypercoagulable states and early thromboembolic lesions in man. In: Erdrich M. (ed.) Advances in automated analysis. 1972 Technicon International Congress. Mediaid, Incorporated; Tarrytown: vol. 4 31.
• 14 Fletcher A, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks J, Hardin W, Raichle M. 1976; a A pilot study of urokinase therapy in cerebral infarction. Stroke 7: 135.
• 15 Fletcher A, Alkjaersig N, Davies A, Lewis M, Brooks J, Hardin W, Landau W, Raichle M. 1976; b Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 7: 337.
• 16 Fletcher A, Alkjaersig N, O’Brien J, Tulevski V. 1977; a Fibrinogen catabolism in the surgically-treated patients and in those with post-operative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with ¹²⁵-I-labelled fibrinogen scan findings. Journal of Laboratory and Clinical Medicine 89: 1349.
• 17 Fletcher A, Alkjaersig N. 1977. b Use of urokinase therapy in cerebrovascular disease. In: Sherry S, Paoletti R. (eds.) Thrombosis and Urokinase. Academic Press; New York: 203.
• 18 Fletcher A, Alkjaersig N. 1977. c Physiological and pathophysiological study of blood coagulation system function by plasma fibrinogen chromatography. In: Ritchie R. (ed.) Automated Immunoanalysis. Marcel Dekker; New York: in press.
• 19 Fletcher A, Alkjaersig N, Ghani M, Tulevski V. 1977 d Blood coagulation system pathophysiology in acute myocardial infarction. The influence of anticoagulant treatment on laboratory findings. Submitted for publication.
• 20 Fletcher A, Alkjaersig N. 1977. e Gel chromatography of fibrinogen in the diagnosis of prethrombotic states. In: Serneri G. G. N, Gensini G. F, Abbate R. (eds.) First Florence Conference on Haemostasis and Thrombosis. Serono Symposia. Academic Press; in press.
• 21 Fletcher A, Alkjaersig N, Peden J, Monofo W. 1977 f In preparation.
• 22 Fletcher A, Alkjaersig N, Burstein R. 1977 g In preparation.
• 23 George C. R, Schlichter S. J, Quadracci L. J, Striker G. F, Harker L. A. 1974; A kinetic evaluation of haemostasis in renal disease. The New England Journal of Medicine 291: 1111.
• 24 Genton E, Steele P. 1977 Platelet survival: Value for the diagnosis of thromboembolism and evaluation of antithrombotic drugs. In: Proceedings of International Symposium on Platelets and Thrombosis. in press.
• 25 Harker L. A, Slichter S. 1970; Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. The New England Journal of Medicine 287: 1302.
• 26 Harker L. A, Slichter S. 1972; Platelet and fibrinogen consumption in man. The New England Journal of Medicine 287: 999.
• 27 Harker L. A, Slichter S. 1974; Arterial and venous thromboembolism: Kinetic characterization and evaluations of therapy. Thrombosis et Diathesis Haemorrhagica 31: 188.
• 28 Haut M. J, Cowan D. H, Harris J. W. 1973; Platelet function and survival in sickle cell disease. Journal of Laboratory and Clinical Medicine 82: 44.
• 29 Kisker C. T, Plummer G, Taylor B, Rush R. 1977; A method for measurement of fibrin monomer with the use of an immune precipitate of fibrinogen. Journal of Laboratory and Clinical Medicine 89: 653.
• 30 Ludlam C. A, Bolton A. E, Moore S, Cash J. D. 1975; New rapid method for diagnosis of deep venous thrombosis. Lancet II: 259.
• 31 Matthias F. R, Reinicke R, Heene D. L. 1977; Affinity chromatography and quantitation of soluble fibrin from plasma. Thrombosis Research 10: 365.
• 32 McKillop C, Howie P, Forbes C, Prentice C. 1976; Soluble fibrinogen/fibrin complexes in pre-eclampsia. Lancet I: 56.
• 33 Nossel H. L, Yudelman I. M, Canfield R, Butler Jr. V, Spanonsis K, Wilner R, Qureshi G. 1974; Measurement of fibrinopeptide A in blood. Journal of Clinical Investigation 54: 43.
• 34 Nossel H. L, Ti M, Kaplan K. L, Spanondis K, Soland T, Butler V. P. 1976; The generation of fibrinopeptide A in clinical blood samples. Evidence for thrombin activity. Journal of Clinical Investigation 58: 1136.
• 35 O’Brien J. R, Tulevski V, Heady J. A. 1972; Rate of fibrinogen turnover in thrombosis. Lancet II: 445.
• 36 O’Brien J. R, Etherington M. D, Jamieson S, Lawford P, Lincoln S. V, Alkjaersig N. 1975; Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thrombosis et Diathesis Haemorrhagica 34: 483.
• 37 Report of Steering Committee. 1972; Effect of aspirin on postoperative venous thrombosis. Lancet II: 441.
• 38 Robson A. M, Cole B. R, Kienstra R. A, Kissane J. M, Alkjaersig N, Fletcher A. 1977; Severe glomerulonephritis complicated by coagulopathy: Treatment with anticoagulation and immuno-suppressive drugs. Journal of Pediatrics 90: 881.
• 39 Schumann M. A, Majerus P. W. 1976; The measurement of thrombin in clotting blood by radioimmunoassay. Journal of Clinical Investigation 58: 1249.
• 40 Shainoff J, Page I. 1962; Significance of cryoprofibrin in fibrinogen/fibrin conversion. Journal of Experimental Medicine 116: 687.
• 41 Simon T. L, Curreri P. W, Harker L. A. 1977; Kinetic characterization of haemostasis in thermal injury. Journal of Laboratory and Clinical Medicine 89: 702.
• 42 van Royen E. A, ten Cate J. W. 1976; Generation of a thrombin-like activity in late pregnancy. Thrombosis Research 8: 487.
• 43 von Hugo R, Graeff H. 1973; Fibrin-I degradation products with a molecular weight higher than fibrinogen. Identification and characterization of in vitro products from human plasma. Thrombosis et Diathesis Haemorrhagica 29: 122.
• 44 Walsh P. N. 1976. Platelets, heparin and blood coagulation. In: Kakkar V. V, Thomas D. P. (eds.) Heparin Chemistry and Clinical Usage. Academic Press; New York: 125.
• 45 Weily H, Steele P. P, Davies H, Pappas G, Genton E. 1974; Platelet survival in patients with substitute heart valves. New England Journal of Medicine 290: 534.
• 46 Yudelman I. M, Nossel H. L, Kaplan K. L. 1977; Fibrinopeptide A (FPA) levels in venous thrombosis and pulmonary embolism before and during anticoagulant therapy. Clinical Research 25: 352A.